ea0099ep247 | Endocrine-Related Cancer | ECE2024
Ntali Georgia
, Kardalas Efstratios
, Beka Aikaterini
, Theodorou Evrydiki
, Zotou Maria
, Lambraki Anastasia
, Tiaka Elisavet
, Antonopoulou Vasiliki
, Karaolidou Frini
, Arapidou Zoi
, Vlassopoulou Barvara
, Karakasis Dimitrios
, Tzenou Tatiana
, Tzannou Ifigenia
, Tsonis Ioannis
, Tzanela Marinella
, Gigantes Stavros
, Baltadakis Ioannis
Introduction: Hematopoietic stem cell transplantation (HSCT) is the standard of care treatment for high-risk hematological malignancies. HSCT recipients are exposed to chemotherapy and/or radiation prior to HSCT, as part of the conditioning, or following HSCT for management of disease relapse. They may receive steroids for chronic graft-versus-host disease (cGvHD) and they are at high risk for endocrine complications. Aim: To evaluate endocrine complicat...